Table 2. Expression of ApoA-1, ApoC-III, and ApoE in Different Tissues.
| Tissues | ApoA-1 | ApoC-III | ApoE | |||
|---|---|---|---|---|---|---|
| Negative (n/%) | Positive (n/%) | Negative (n/%) | Positive (n/%) | Negative (n/%) | Positive (n/%) | |
| SCLC (89) | 27.0% (24/89) | 73.0% (65/89)* | 41.6% (37/89) | 58.4% (52/89)* | 22.5% (20/89) | 77.5% (69/89) |
| NSCLC (19) | 42.1% (8/19) | 57.9% (11/19) | 31.6% (6/19) | 68.4% (13/19) | 26.3% (5/19) | 73.7% (14/19) |
| Normal (12) | 50% (6/12) | 50% (6/12) | 25% (3/12) | 75% (9/12) | 25% (3/12) | 75% (9/12) |
| Squamous cell carcinoma (8) | 50% (4/8) | 50% (4/8) | 25% (2/8) | 75% (17/19) | 25% (2/8) | 75% (6/8) |
| Adenocarcinoma (11) | 36.4% (4/11) | 63.6% (7/11) | 36.4% (4/11) | 63.6% (7/11) | 27.4% (3/11) | 72.6% (8/11) |
SCLC, small cell lung cancer; NSCLC, non-small cell lung cancer.
*p<0.05 (compared with NSCLC or normal lung tissue).